IFOWONCO's proprietary technology platform has proven to be best in class through independent assessment. In the second Grand Challenge competition sponsored by the National Institute of Health and the pharmaceutical company Roche. This competition took place between fall 2016 and spring 2017 at the University of California, San Diego, USA.
In this assessment our technology was ranked first in the evaluation of free-energy of binding sub-challenge and second in the pose prediction challenge.